BIOGEN INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biogen Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2010 to Q3 2024.
  • Biogen Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was -$75M, a 15.7% decline year-over-year.
  • Biogen Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was -$281M, a 2.3% increase year-over-year.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2023 was -$274M, a 4.14% decline from 2022.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2022 was -$264M, a 6.85% decline from 2021.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2021 was -$247M, a 20.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$281M -$75M -$10.2M -15.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 -$270M -$72.9M +$1.2M +1.62% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$272M -$76.1M +$2.8M +3.55% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 -$274M -$56.6M +$12.8M +18.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 -$287M -$64.8M +$900K +1.37% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 -$288M -$74.1M -$16.1M -27.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$272M -$78.9M -$8.5M -12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 -$264M -$69.4M -$8.8M -14.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 -$255M -$65.7M -$8.1M -14.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$247M -$58M -$2.2M -3.94% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 -$244M -$70.4M +$2.2M +3.03% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 -$247M -$60.6M -$10.2M -20.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 -$236M -$57.6M -$22.2M -62.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 -$214M -$55.8M -$6.3M -12.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 -$208M -$72.6M -$3.4M -4.91% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$205M -$50.4M +$87M +63.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 -$292M -$35.4M +$12.4M +25.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 -$304M -$49.5M +$5.5M +10% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 -$309M -$69.2M -$118M -241% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 -$191M -$137M +$160M +53.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q3 2019 -$351M -$47.8M -$88.2M -218% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-21
Q2 2019 -$263M -$55M -$96.4M -233% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 -$166M $49M +$2.3M +4.93% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 -$169M -$297M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q3 2018 $40.4M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 $41.4M Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $46.7M Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q3 2011 $36.6M -$6.2M -14.5% Jul 1, 2011 Sep 30, 2011 10-Q 2011-10-28
Q2 2011 $36.1M -$13.3M -26.9% Apr 1, 2011 Jun 30, 2011 10-Q 2011-07-26
Q3 2010 $42.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 $49.4M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.